Identification of Epsin1 as a regulator for hepatic lipid and glucose metabolism  

作　　者：Xiaohua Huang Long Jin Zhengfeng Fang Lianqiang Che Yan Lin Shengyu Xu Yong Zhuo Mingzhou Li De Wu Bin Feng 

机构地区：[1]Animal Nutrition Institute,Sichuan Agricultural University,Chengdu,Sichuan 611130,China [2]Key Laboratory of Animal Disease-Resistant Nutrition of Ministry of Education,Sichuan Agricultural University,Chengdu,Sichuan 611130,China [3]College of Animal Science,Sichuan Agricultural University,Chengdu,Sichuan 611130,China

出　　处：《Genes & Diseases》2023年第1期72-75,共4页基因与疾病（英文）

基　　金：This study was supported by the National Natural Science Foundation of China(No.31900834);the China's Overseas Expertise Introduction Project for Discipline Innovation("111 Project")(No.D17015).

摘　　要：Obesity related non-alcoholic fatty liver disease(NAFLD),which can progress to steatohepatitis and insulin resistance,has become a major chronic liver disease worldwide.1 As an adaptor of clathrin-mediated endocytosis,Epsin1 plays a role in many diseases,including tumors,atherosclerosis and diabetic wound healing.

关 键 词：METABOLISM HEALING WOUND 

分 类 号：R575.5[医药卫生—消化系统]